Is the Disease Burden from COPD in Norway Falling off? A Study of Time Trends in Three Different Data Sources

References

• WipfliH, SametJM. One hundred years in the making: the global tobacco epidemic. Annu Rev Public Health. 2016;37:149–166. doi:10.1146/annurev-publhealth-032315-02185026772406
   PubMed Web of Science ®Google Scholar
• Statistics Norway; 2019 Tobacco, alcohol and other drugs. Available from: www.ssb.no/en/statbank/table/07662. Accessed February 7, 2020.
   Google Scholar
• KohansalR, Martinez-CamblorP, AgustiA, BuistAS, ManninoDM, SorianoJB. The natural history of chronic airflow obstruction revisited: an analysis of the Framingham offspring cohort. Am J Respir Crit Care Med. 2009;180(1):3–10. doi:10.1164/rccm.200901-0047OC19342411
   PubMed Web of Science ®Google Scholar
• SorianoJB, AncocheaJ, MiravitllesM, et al. Recent trends in COPD prevalence in Spain: a repeated cross-sectional survey 1997–2007. Eur Respir J. 2010;36(4):758–765. doi:10.1183/09031936.0013840919996189
   PubMed Web of Science ®Google Scholar
• BischoffEW, SchermerTR, BorH, BrownP, vanWC, van den BoschWJ. Trends in COPD prevalence and exacerbation rates in Dutch primary care. Br J Gen Pract. 2009;59(569):927–933. doi:10.3399/bjgp09X47307919891824
   PubMed Web of Science ®Google Scholar
• BackmanH, ErikssonB, RonmarkE, et al. Decreased prevalence of moderate to severe COPD over 15 years in northern Sweden. Respir Med. 2016;114:103–110. doi:10.1016/j.rmed.2016.03.01327109819
   PubMed Web of Science ®Google Scholar
• BhattaL, LeivsethL, MaiXM, et al. Prevalence and trend of COPD from 1995–1997 to 2006–2008: the HUNT study, Norway. Respir Med. 2018;138:50–56. doi:10.1016/j.rmed.2018.03.02029724393
   PubMed Web of Science ®Google Scholar
• ReitsmaMB, FullmanN, NgM. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet. 2017;389(10082):1885–1906. doi:10.1016/S0140-6736(17)30819-X28390697
   PubMed Web of Science ®Google Scholar
• VieiraR, FonsecaJA, LopesF, FreitasA. Trends in hospital admissions for obstructive lung disease from 2000 to 2010 in Portugal. Respir Med. 2016;116:63–69. doi:10.1016/j.rmed.2016.05.01827296823
   PubMed Web of Science ®Google Scholar
• LiuH, WangN, ChenW, et al. Hospitalization Trends in Adult Patients with COPD and other respiratory diseases in Northeast China from 2005 to 2015. Biomed Res Int. 2018;2018:1060497.29581961
   PubMed Web of Science ®Google Scholar
• JacobsenBK, EggenAE, MathiesenEB, WilsgaardT, NjolstadI. Cohort profile: the Tromso Study. Int J Epidemiol. 2012;41(4):961–967. doi:10.1093/ije/dyr04921422063
   PubMed Web of Science ®Google Scholar
• MirzaS, ClayRD, KoslowMA, ScanlonPD. COPD guidelines: a Review of the 2018 GOLD report. Mayo Clin Proc. 2018;93(10):1488–1502. doi:10.1016/j.mayocp.2018.05.02630286833
   PubMed Web of Science ®Google Scholar
• MillerMR, HankinsonJ, BrusascoV, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.0003480516055882
   PubMed Web of Science ®Google Scholar
• [No authors listed]. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med. 1995;152(3):1107–1136. doi:10.1164/ajrccm.152.3.76637927663792
   PubMed Web of Science ®Google Scholar
• VoldML, AaseboU, MelbyeH. Low FEV1, smoking history, and obesity are factors associated with oxygen saturation decrease in an adult population cohort. Int J Chron Obstruct Pulmon Dis. 2014;9:1225–1233. doi:10.2147/COPD.S6943825364242
   PubMed Web of Science ®Google Scholar
• LanghammerA, JohannessenA, HolmenTL, et al. Global Lung Function Initiative 2012 reference equations for spirometry in the Norwegian population. Eur Respir J. 2016;48(6):1602–1611. doi:10.1183/13993003.00443-201627824594
   PubMed Web of Science ®Google Scholar
• VoldML, AaseboU, HjalmarsenA, MelbyeH. Predictors of oxygen saturation ≤95% in a cross-sectional population based survey. Respir Med. 2012;106(11):1551–1558. doi:10.1016/j.rmed.2012.06.01622795506
   PubMed Web of Science ®Google Scholar
• McCullaghP. Generalized Linear Models. 2nd ed. Chapman & Hall; 1989.
   Google Scholar
• HauganT, BakkenIJ, StorroO, OienT, LanghammerA. Utvikliing i diagnostisering og helsetjenesteforbruk ved obstruktiv lungesykdom [Utilization of diagnostic tools and health care services for obstructive lung disease]. Tidsskr nor Laegeforen. 2008;128(21):2431–2434.19096464
   PubMedGoogle Scholar
• Ryan-IbarraS, MiletM, LutzkerL, RodriguezD, InduniM, KreutzerR. Age, period, and cohort effects in adult lifetime asthma prevalence in California: an application of hierarchical age-period-cohort analysis. Ann Epidemiol. 2016;26(2):87–92. doi:10.1016/j.annepidem.2015.12.00226762964
   PubMed Web of Science ®Google Scholar
• MulpuruS, LiL, YeL, et al. Effectiveness of influenza vaccination on hospitalizations and risk factors for severe outcomes in hospitalized patients with COPD. Chest. 2019;155(1):69–78. doi:10.1016/j.chest.2018.10.04430616737
   PubMed Web of Science ®Google Scholar
• PuhanMA, Gimeno-SantosE, CatesCJ, TroostersT. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2016;12:CD005305. doi:10.1002/14651858.CD003091.pub427930803
   PubMed Web of Science ®Google Scholar
• OieLR, MadsbuMA, GiannadakisC, et al. Validation of intracranial hemorrhage in the Norwegian patient registry. Brain Behav. 2018;8(2):e00900. doi:10.1002/brb3.2018.8.issue-229484261
   PubMed Web of Science ®Google Scholar
• VarmdalT, BakkenIJ, JanszkyI, et al. Comparison of the validity of stroke diagnoses in a medical quality register and an administrative health register. Scand J Public Health. 2016;44(2):143–149. doi:10.1177/140349481562164126660300
   PubMed Web of Science ®Google Scholar
• VarmaghaniM, DehghaniM, HeidariE, SharifiF, MoghaddamSS, FarzadfarF. Global prevalence of chronic obstructive pulmonary disease: systematic review and meta-analysis. East Mediterr Health J. 2019;25(1):47–57. doi:10.26719/emhj.18.01430919925
   PubMed Web of Science ®Google Scholar
• JohannessenA, OmenaasER, BakkePS, GulsvikA. Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study. Thorax. 2005;60(10):842–847. doi:10.1136/thx.2005.04394316085729
   PubMed Web of Science ®Google Scholar
• DalbakLG, StraandJ, MelbyeH. Should pulse oximetry be included in GPs’ assessment of patients with obstructive lung disease? Scand J Prim Health Care. 2015;33(4):305–310. doi:10.3109/02813432.2015.111728326654760
   PubMed Web of Science ®Google Scholar
• MannsverkJ, WilsgaardT, MathiesenEB, et al. Trends in modifiable risk factors are associated with declining incidence of hospitalized and nonhospitalized acute coronary heart disease in a population. Circulation. 2016;133(1):74–81. doi:10.1161/CIRCULATIONAHA.115.01696026582781
   PubMed Web of Science ®Google Scholar
• RottenkolberM, VoogdE, vanDL, et al. Time trends of period prevalence rates of patients with inhaled long-acting beta-2-agonists-containing prescriptions: a European comparative database study. PLoS One. 2015;10(2):e0117628. doi:10.1371/journal.pone.011762825706152
   PubMed Web of Science ®Google Scholar
• ReilevM, PottegardA, DavidsenJR, et al. Seventeen-year nationwide trends in use of long-acting bronchodilators and inhaled corticosteroids among adults - a danish drug utilization study. Basic Clin Pharmacol Toxicol. 2018;123(1):58–64. doi:10.1111/bcpt.2018.123.issue-129417739
   PubMed Web of Science ®Google Scholar
• AnthonisenNR, ConnettJE, MurrayRP. Smoking and lung function of Lung Health Study participants after 11 years. Am J Respir Crit Care Med. 2002;166(5):675–679. doi:10.1164/rccm.211209612204864
   PubMed Web of Science ®Google Scholar
• DanielsenSE, LochenML, MedboA, VoldML, MelbyeH. A new diagnosis of asthma or COPD is linked to smoking cessation - the Tromso study. Int J Chron Obstruct Pulmon Dis. 2016;11:1453–1458. doi:10.2147/COPD.S10804627418818
   PubMed Web of Science ®Google Scholar
• HoritaN, GotoA, ShibataY, et al. Long-acting muscarinic antagonist (LAMA) plus long-acting beta-agonist (LABA) versus LABA plus inhaled corticosteroid (ICS) for stable chronic obstructive pulmonary disease (COPD). Cochrane Database Syst Rev. 2017;2:CD012066.28185242
   PubMed Web of Science ®Google Scholar
• HetlevikO, MelbyeH, GjesdalS. GP utilisation by education level among adults with COPD or asthma: a cross-sectional register-based study. NPJ Prim Care Respir Med. 2016;26:16027. doi:10.1038/npjpcrm.2016.2727279354
   PubMed Web of Science ®Google Scholar
• HoT, CusackRP, ChaudharyN, SatiaI, KurmiOP. Under- and over-diagnosis of COPD: a global perspective. Breathe (Sheff). 2019;15(1):24–35. doi:10.1183/20734735.0346-201830838057
   PubMedGoogle Scholar